Investors
Financials
Financial Calendar
Jan 15, 2025 – Fourth Quarter 2024 Sales
Apr 24, 2025 – Full-Year 2024 Financial Results
Jun 5, 2025 – Annual General Meeting
Oct 2, 2025 – Half-Year 2025 Financial Results
Financial Calendar
Jan 15, 2025 – Fourth Quarter 2024 Sales
Apr 24, 2025 – Full-Year 2024 Financial Results
Jun 5, 2025 – Annual General Meeting
Oct 2, 2025 – Half-Year 2025 Financial Results
Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update
Mauna Kea Technologies Announces its 2025 Financial Calendar
Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales
Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024
2023 Annual Financial Report
Mauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales
Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank
Mauna Kea Technologies Announces Initiation of Coverage by EuroLand Corporate
Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42% vs 2022
Mauna Kea Technologies Reports 74% Increase in 9-Month 2023 Sales
Mauna Kea Technologies Reports H1 2023 Financial Results
Mauna Kea Technologies Reports Second Quarter and First Half 2023 Revenue
News
Cellvizio® Now Recommended in New European Society of Gastrointestinal Endoscopy Technical Guideline for Pancreatic Cyst Diagnosis
Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers
